Trial
NCT02395848
Efficacy of 30-day Duration of Fidaxomicin for Recurrent C. Difficile Infection
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
McMaster University
Collaborators
—
Condition
Clostridium Difficile Infection
Intervention
Fidaxomicin
Why stopped
Insufficient resource to complete the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-03-24